111 related articles for article (PubMed ID: 24098016)
1. Unraveling the genetic predisposition to differentiated thyroid carcinoma.
de la Chapelle A
J Clin Endocrinol Metab; 2013 Oct; 98(10):3974-6. PubMed ID: 24098016
[No Abstract] [Full Text] [Related]
2. Genetic predisposition to papillary thyroid cancer.
Kula D; Kalemba M; Jurecka-Lubieniecka B; Puch Z; Kowalska M; Tyszkiewicz T; Kowal M; Handkiewicz-Junak D
Endokrynol Pol; 2010; 61(5):486-9. PubMed ID: 21049463
[TBL] [Abstract][Full Text] [Related]
3. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma.
Bonora E; Rizzato C; Diquigiovanni C; Oudot-Mellakh T; Campa D; Vargiolu M; Guedj M; ; McKay JD; Romeo G; Canzian F; Lesueur F
Int J Cancer; 2014 May; 134(9):2098-107. PubMed ID: 24127282
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
[TBL] [Abstract][Full Text] [Related]
5. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia.
Tcheandjieu C; Lesueur F; Sanchez M; Baron-Dubourdieu D; Guizard AV; Mulot C; Laurent-Puig P; Schvartz C; Truong T; Guenel P
Int J Cancer; 2016 Aug; 139(3):617-27. PubMed ID: 26991144
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study on differentiated thyroid cancer.
Köhler A; Chen B; Gemignani F; Elisei R; Romei C; Figlioli G; Cipollini M; Cristaudo A; Bambi F; Hoffmann P; Herms S; Kalemba M; Kula D; Harris S; Broderick P; Houlston R; Pastor S; Marcos R; Velázquez A; Jarzab B; Hemminki K; Landi S; Försti A
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1674-81. PubMed ID: 23894154
[TBL] [Abstract][Full Text] [Related]
7. Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk.
Figlioli G; Köhler A; Chen B; Elisei R; Romei C; Cipollini M; Cristaudo A; Bambi F; Paolicchi E; Hoffmann P; Herms S; Kalemba M; Kula D; Pastor S; Marcos R; Velázquez A; Jarząb B; Landi S; Hemminki K; Försti A; Gemignani F
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2084-92. PubMed ID: 25029422
[TBL] [Abstract][Full Text] [Related]
8. Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma.
Pellé L; Cipollini M; Tremmel R; Romei C; Figlioli G; Gemignani F; Melaiu O; De Santi C; Barone E; Elisei R; Seiser E; Innocenti F; Zanger UM; Landi S
Arch Toxicol; 2016 Dec; 90(12):3099-3109. PubMed ID: 26783003
[TBL] [Abstract][Full Text] [Related]
9. Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis.
Cavaco BM; Batista PF; Sobrinho LG; Leite V
J Clin Endocrinol Metab; 2008 Nov; 93(11):4426-30. PubMed ID: 18765515
[TBL] [Abstract][Full Text] [Related]
10. The role of Ile3434Thr XRCC7 gene polymorphism in differentiated thyroid cancer risk in an Iranian population.
Rahimi M; Fayaz S; Fard-Esfahani A; Modarressi MH; Akrami SM; Fard-Esfahani P
Iran Biomed J; 2012; 16(4):218-22. PubMed ID: 23183621
[TBL] [Abstract][Full Text] [Related]
11. Acquisition of BRAF gene mutations is not a requirement for nodal metastasis of papillary thyroid carcinoma.
Trovisco V; Couto JP; Cameselle-Teijeiro J; de Castro IV; Fonseca E; Soares P; Sobrinho-Simões M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):683-5. PubMed ID: 18363883
[No Abstract] [Full Text] [Related]
12. Discovery of common variants associated with low TSH levels and thyroid cancer risk.
Gudmundsson J; Sulem P; Gudbjartsson DF; Jonasson JG; Masson G; He H; Jonasdottir A; Sigurdsson A; Stacey SN; Johannsdottir H; Helgadottir HT; Li W; Nagy R; Ringel MD; Kloos RT; de Visser MC; Plantinga TS; den Heijer M; Aguillo E; Panadero A; Prats E; Garcia-Castaño A; De Juan A; Rivera F; Walters GB; Bjarnason H; Tryggvadottir L; Eyjolfsson GI; Bjornsdottir US; Holm H; Olafsson I; Kristjansson K; Kristvinsson H; Magnusson OT; Thorleifsson G; Gulcher JR; Kong A; Kiemeney LA; Jonsson T; Hjartarson H; Mayordomo JI; Netea-Maier RT; de la Chapelle A; Hrafnkelsson J; Thorsteinsdottir U; Rafnar T; Stefansson K
Nat Genet; 2012 Jan; 44(3):319-22. PubMed ID: 22267200
[TBL] [Abstract][Full Text] [Related]
13. Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma.
Zhang F; Xu L; Wei Q; Song X; Sturgis EM; Li G
Surgery; 2013 May; 153(5):711-7. PubMed ID: 23218882
[TBL] [Abstract][Full Text] [Related]
14. Fas single nucleotide polymorphisms and risk of thyroid and salivary gland carcinomas: a case-control analysis.
Ho T; Li G; Zhao C; Zheng R; Wei Q; Sturgis EM
Head Neck; 2008 Mar; 30(3):297-305. PubMed ID: 17657791
[TBL] [Abstract][Full Text] [Related]
15. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
[TBL] [Abstract][Full Text] [Related]
16. Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer.
Adjadj E; Schlumberger M; de Vathaire F
Lancet Oncol; 2009 Feb; 10(2):181-90. PubMed ID: 19185836
[TBL] [Abstract][Full Text] [Related]
17. Identification of epistatic interactions through genome-wide association studies in sporadic medullary and juvenile papillary thyroid carcinomas.
Luzón-Toro B; Bleda M; Navarro E; García-Alonso L; Ruiz-Ferrer M; Medina I; Martín-Sánchez M; Gonzalez CY; Fernández RM; Torroglosa A; Antiñolo G; Dopazo J; Borrego S
BMC Med Genomics; 2015 Dec; 8():83. PubMed ID: 26690675
[TBL] [Abstract][Full Text] [Related]
18. Investigation of VEGF and IL-8 Gene Polymorphisms in Patients with Differentiated Thyroid Cancer.
Kilic I; Guldiken S; Sipahi T; Palabiyik O; Akker M; Celik O; Soysal-Atile N; Tuncbilek N; Guven HM; Gundogdu AS; Sut N
Clin Lab; 2016 Dec; 62(12):2319-2325. PubMed ID: 28164553
[TBL] [Abstract][Full Text] [Related]
19. Clinical behavior and genetics of nonsyndromic, familial nonmedullary thyroid cancer.
Bauer AJ
Front Horm Res; 2013; 41():141-8. PubMed ID: 23652675
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of thyroid cancer.
Rebaї M; Rebaї A
Genet Res (Camb); 2016 May; 98():e7. PubMed ID: 27174043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]